| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
2.0 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
1.997 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
1.997 |
Evidence |
|
| GRB10 |
IPI00012752 |
ACP1 |
ACP1: Low molecular weight phosphotyrosine protein phosphatase |
1.997 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
GRB10 |
IPI00012752 |
1.997 |
Evidence |
|
| CAV1 |
CAV1, CAV: Caveolin-1 |
GRB10 |
IPI00012752 |
1.997 |
Evidence |
|
| PRKDC |
PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
1.997 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
USP9X |
USP9X, DFFRX, USP9: Probable ubiquitin carboxyl-terminal hydrolase FAF-X |
1.997 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
CDC2 |
CDC2: Cell division control protein 2 homolog |
1.997 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
1.997 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
PTPRA |
IPI00032333 |
1.997 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
USP9X |
USP9X, DFFRX, USP9: Probable ubiquitin carboxyl-terminal hydrolase FAF-X |
1.997 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
CAV1 |
CAV1, CAV: Caveolin-1 |
1.997 |
Evidence |
|
| COL11A1 |
COL11A1, COLL6: Collagen alpha-1(XI) chain precursor |
F5 |
F5: Coagulation factor V precursor |
1.997 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
PDE6G |
DKFZp686N1686, PDE6G, hCG_38056: Putative uncharacterized protein DKFZp686N1686 |
1.997 |
Evidence |
|
| EIF4E |
EIF4E, EIF4EL1, EIF4F: Eukaryotic translation initiation factor 4E |
MAP3K9 |
MAP3K9, MLK1, PRKE1: Mitogen-activated protein kinase kinase kinase 9 |
1.997 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PLA2G4A |
PLA2G4A, CPLA2, PLA2G4: Cytosolic phospholipase A2 |
1.997 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
HLA-A |
IPI00719058 |
1.997 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
COL11A1 |
COL11A1, COLL6: Collagen alpha-1(XI) chain precursor |
1.997 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
COL11A1 |
COL11A1, COLL6: Collagen alpha-1(XI) chain precursor |
1.997 |
Evidence |
|
| PRMT5 |
PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
1.997 |
Evidence |
|
| CDC23 |
CDC23: Cell division cycle protein 23 homolog |
EPB41L3 |
EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 |
1.997 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
MYO3A |
MYO3A: Myosin IIIA |
1.997 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
AKAP8L |
AKAP8L, NAKAP95, HRIHFB2018: A-kinase anchor protein 8-like |
1.997 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
EXOC2 |
IPI00215805 |
1.997 |
Evidence |
|